Gender-related differences in clinical course of Crohn's disease in an Asian population: A retrospective cohort review;Diferenças relativas aos sexos no curso clínico da doença de Crohn em uma população da Ásia: uma revisão de coorte retrospectivo. Arq Gastroenterol

Arquivos de Gastroenterologia

Volumn 51, Issue 2, 2014, Pages 90-96

  Law, Siu Tong ^a   Li, Kin Kong ^a  

^a TUEN MUN HOSPITAL   (Hong Kong)

Author keywords

Crohn disease; Gender identity; Immunosuppressive agents; Smoking; Therapeutic use

Indexed keywords

AZATHIOPRINE; MERCAPTOPURINE; METHOTREXATE;

ADULT; ALLERGIC RASH; ARTICLE; BODY MASS; BONE MARROW SUPPRESSION; CAPSULE ENDOSCOPY; COHORT ANALYSIS; CROHN DISEASE; CROHN DISEASE ACTIVITY INDEX; DISEASE COURSE; DIZZINESS; FEMALE; FLUOROSCOPY; HERPES ZOSTER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NAUSEA; PHENOTYPE; PNEUMOCYSTIS PNEUMONIA; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SINGLE BALLOON ENTEROSCOPY; SMOKING; TOXIC HEPATITIS; TREATMENT OUTCOME; ADOLESCENT; AGED; CHILD; CHINA; INFANT; MIDDLE AGED; NEWBORN; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PROGNOSIS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CHINA; CROHN DISEASE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PHENOTYPE; PROGNOSIS; RETROSPECTIVE STUDIES; SEX FACTORS; YOUNG ADULT;

EID: 84904114171     PISSN: 00042803     EISSN: 16784219     Source Type: Journal    
DOI: 10.1590/S0004-28032014000200004     Document Type: Article

References (46)

1. Aberra FN, Lichtenstein GR. Methods to avoid infections in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:685-95.
2. Asakura K, Nishiwaki Y, Inoue N, Hibi T, Watanabe M, Takebayashi T. Prevalence of ulcerative colitis and Crohn's disease in Japan. J Gastroenterol. 2009;44:659-65.
3. Baars JE, Zelinkova Z, Mensink PB, Markus T, Looman CW, Kuipers EJ, et al. High therapy adherence but substantial limitations to daily activities amongst members of the Dutch inflammatory bowel disease patients' organization: a patient empowerment study. Aliment Pharmacol Ther. 2009;8:864-72.
4. Bermas BL, Hill JA. Effects of immunosuppressive drugs during pregnancy. Arthritis Rheum. 1995;12:1722-32.
5. Blumenstein I, Herrmann E, Filmann N, Zosel C, Tacke W, Bock H, et al. Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activity: a subgroup analysis of a large multi-centre, prospective, internet-based study. J Crohns Colitis. 2011;5:203-10.
6. Bokemeyer B, Teml A, Roggel C, Hartmann P, Fischer C, Schaeffeler E, et al. Adherence to thiopurine treatment in out-patients with Crohn's disease. Aliment Pharmacol Ther. 2007;2:217-25.
7. Calkins BM, Mendeloff AI. The epidemiology of idiopathic inflammatory bowel disease. In: Kirsner JB, Shorter RG, eds. Inflammatory bowel disease, 4th ed. Baltimore: Williams & Wilkins. 1995:31-68.
8. Chow DK, Leong RW, Lai LH, Wong GL, Leung WK, Chan FK, Sung JJ. Changes in Crohn's disease phenotype over time in the Chinese population: validation of the Montreal classification system. Inflamm Bowel Dis. 2008;14:536-41.
9. Das K, Ghoshal UC, Dhali GK, Benjamin J, Ahuja V, Makharia GK. Crohn's disease in India: a multicenter study from a country where tuberculosis is endemic. Dig Dis Sci. 2009;54:1099-107.
10. Ediger JP, Walker JR, Graff L, Lix L, Clara I, Rawsthorne P, et al. Predictors of medication adherence in inflammatory bowel disease. Am J Gastroenterol. 2007;7:1417-26.
11. Farmer RG, Whelan G, Fazio VW. Long-term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis. Gastroenterology. 1985;88:1818-25.
12. Farrokhyar F, Swarbrick ET, Irvine EJ. A critical review of epidemiological studies in inflammatory bowel disease. Scand J Gastroenterol. 2001;36:2-15.Erratum in: Scand J Gastroenterol. 2001;36:facing 561.
13. Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn's disease and ulcerative colitis: A study of 700 patients. Medicine. 1976;55:404-12.
14. Heetun ZS, Byrnes C, Neary P, O'Morain C. Review article: reproduction in the patient with inflammatory bowel disease. Aliment Pharmacol Ther. 2007;4:513-33.
15. Ishige T, Tomomasa T, Takebayashi T Asakura K, Watanabe M, Suzuki T, et al. Inflammatory bowel disease in children: epidemiological analysis of the nationwide IBD registry in Japan. J Gastroenterol. 2010;45:911-7.
16. Jiang L, Xia B, Li J, Ye M, Yan W, Deng C, et al. Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China. Inflamm Bowel Dis. 2006;12:212-7.
17. Johnson GJ, Cosnes J, Mansfield JC. Review article: smoking cessation as primary therapy to modify the course of Crohn's disease. Aliment Pharmacol Ther. 2005;21:921e31.
18. Kane SV, Flicker M, Katz-Nelson F. Tobacco use is associated with accelerated clinical recurrence of Crohn's disease after surgically induced remission. J Clin Gastroenterol. 2005;39:32-5.
19. Kyle J. Crohn's disease in the northeastern and northern isles of Scotland: An epidemiological review. Gastroenterology. 1992;103:392-9.
20. Latour P, Belaiche J, Louis E, Fontaine F, Deflandre J, Loly J, et al. Incidence of inflammatory bowel disease in the province of Liège (Belgium). Acta Gastroenterol Belg. 1996;59:3-6.
21. Lee YM, Fock K, See SJ. Racial differences in the prevalence of ulcerative colitis and Crohn's disease in Singapore. J Gastroenterol. Hepatol. 2000;15:622-5.
22. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989;170:2-6.
23. Loftus EV Jr, Schoenfeld P, Sandborn WJ. The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review. Aliment Pharmacol Ther. 2002;16:51-60.
24. Luo CH, Wexner SD, Liu QS, Li L, Weiss E, Zhao RH. The differences between American and Chinese patients with Crohn's disease. Colorectal Dis. 2011;13:166-70.
25. Mowat C, Cole A, Windsor A, Ahmad T, Arnott I, Driscoll R, et al. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2011;60:571-607.
26. Ooi CJ, Fock KM, Makharia GK, Goh KL, Ling KL, Hilmi I. The Asia-Pacific consensus on ulcerative colitis. J Gastroenterol. Hepatol. 2010;25:453-68.
27. Oriuchi T, Hiwatashi N, Kinouchi Y. Clinical course and longterm prognosis of Japanese patients with Crohn's disease: predictive factors, rates of operation, and mortality. J Gastroenterol. 2003;38:942-53.
28. Prideaux L, Kamm MA, De Cruz PP, Chan FK, Ng SC. Inflammatory bowel disease in Asia: a systematic review. J Gastroenterol Hepatol. 2012;27:1266-80.
29. Rankin GB, Watts HD, Melnyk CS, Kelley ML Jr. The national cooperative Crohn's disease study: Extraintestinal manifestations and perianal complications. Gastroenterology. 1979;77:914-20.
30. Roubenoff R, Hoyt J, Petri M, Hochberg MC, Hellmann DB. Effects of anti-inflammatory and immunosuppressive drugs on pregnancy and fertility. Semin Arthritis Rheum. 1988;2:88-110.
31. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749-53.
32. Shin DH, Sinn DH, Kim YH, Kim JY, Chang DK, Kim EJ, et al. Increasing incidence of inflammatory bowel disease among young men in Korea between 2003 and 2008. Dig Dis Sci. 2011;56:1154-9.
33. Shivananda S, Peña AS, Nap M, Weterman IT, Mayberry JF, Ruitenberg EJ, Hoedemaeker PJ. Epidemiology of Crohn's disease in region Leiden, the Netherlands. A population study from 1979 to 1983. Gastroenterology. 1987;93:966-74.
34. Song XM, Gao X, Li MZ, Chen ZH, Chen SC, Hu PJ, et al. Clinical features and risk factors for primary surgery in 205 patients with Crohn's disease: analysis of a South China cohort. Dis Colon Rectum. 2011;54:1147-54.
35. Subasinghe D, Nawarathna NM, Samarasekera DN. Disease characteristics of Inflammatory Bowel Disease (IBD): findings from a Tertiary Care Centre in South Asia. J Gastrointest. Surg. 2011;15:1562-7.
36. Sung JJ, Kamm MA, Marteau P. Asian perspectives in the management of inflammatory bowel disease: findings from a recent survey. J Gastroenterol Hepatol. 2010;25:183-93.
37. Van Gossum A, Adler M, De Reuck M, Devis G, Fiasse R, Vanheurverzwijn R, Willocx R. Epidemiology of inflammatory bowel disease in Brussels' area (1992-1993). Acta Gastroenterol Belg. 1996;59:7-9.
38. Vavricka SR, Brun L, Ballabeni P, Pittet V, Prinz Vavricka BM, Zeitz J, Rogler G, et al. Schoepfer AM. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol. 2011;106:110-9.
39. Wagtmans MJ, Verspaget HW, Lamers CB, van Hogezand RA. Gender-related differences in the clinical course of Crohn's disease. Am J Gastroenterol. 2001;96:1541-6.
40. Whelan G. Epidemiology of inflammatory bowel disease. Med Clin North Am. 1990;74:1-12.
41. Willis FR, Findlay CA, Gorrie MJ, Watson MA, Wilkinson AG, Beattie TJ. Children of renal transplant recipient mothers. Children of renal transplant recipient mothers. J Paediatr Child Health. 2000;3:230-5.
42. Yang SK, Yun S, Kim JH, Park JY, Kim HY, Kim YH, et al. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study. Inflamm Bowel Dis. 2008;14:542-9.
43. Yao T, Matsui T, Hiwatashi N. Crohn's disease in Japan: diagnostic criteria and epidemiology. Dis. Colon Rectum. 2000;43:S85-93.
44. Ye BD, Yang SK, Cho YK, Park SH, Yang DH, Yoon SM, et al. Clinical features and long-term prognosis of Crohn's disease in Korea. Scand. J Gastroenterol. 2010;45:1178-85.
45. Zelinkova Z, Mensink PB, Dees J, Kuipers EJ, van der Woude CJ. Reproductive wish represents an important factor influencing therapeutic strategy in inflammatory bowel diseases. Scand J Gastroenterol. 2010;1:46-50.
46. Zheng JJ, Zhu XS, Huangfu Z, Shi XH, Guo ZR. Prevalence and incidence rates of Crohn's disease in mainland China: a meta-analysis of 55 years of research. J Dig Dis. 2010;11:161-6